Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world’s leading cause of disability, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilella, Antonietta, Ruozi, Barbara, Belletti, Daniela, Pederzoli, Francesca, Galliani, Marianna, Semeghini, Valentina, Forni, Flavio, Zoli, Michele, Vandelli, Maria Angela, Tosi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491652/
https://www.ncbi.nlm.nih.gov/pubmed/26102358
http://dx.doi.org/10.3390/pharmaceutics7020074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491652/
https://www.ncbi.nlm.nih.gov/pubmed/26102358
http://dx.doi.org/10.3390/pharmaceutics7020074

Ejemplares similares